|Bid||104.20 x 0|
|Ask||104.35 x 0|
|Day's Range||103.65 - 104.40|
|52 Week Range||66.12 - 104.75|
|PE Ratio (TTM)||61.46|
|Forward Dividend & Yield||1.00 (0.98%)|
|1y Target Est||88.85|
Sweden's Elekta pushed back its order target for a new radiation therapy machine which is meant to drive its future sales growth on Thursday as it reported higher quarterly core earnings than expected. Shares in Elekta fell this month after it announced delays to its magnetic resonance radiation therapy machine Unity and said it now expected European health and safety certification towards the end of the first half of next year rather than late 2017. Chief Financial Officer Gustaf Salford said Elekta was now also delaying its application for approval of Unity by the U.S. Food and Drug Administration to late in the second half of 2018.
Elekta, MRI technology partner Philips and seven world-renowned cancer institutions collaborate to bring together the best of imaging and radiation therapy in a single device CHICAGO , Nov. 21, 2017 /PRNewswire/ ...
Radiotherapy gear maker Elekta posted on Wednesday lower quarterly core earnings than expected, but orders matched forecasts and the firm repeated a full-year margin target. * Fiscal Q1 EBITA excl. one-offs ...
Swedish radiotherapy equipment maker Elekta posted on Thursday a surprise drop in fiscal fourth-quarter core earnings and order intake fell far below forecasts, sending shares sharply lower. * Feb-Apr ...